bims-microg Biomed News
on Microglia in health and disease
Issue of 2026–11–15
fourteen papers selected by
Marcus Karlstetter, Universität zu Köln



  1. Metabolism. 2026 Nov 10. pii: S0026-0495(26)00355-0. [Epub ahead of print] 156841
       BACKGROUND: Systemic metabolic abnormalities are established drivers of cognitive decline, traditionally attributed to secondary sequelae of cerebrovascular dysfunction. However, cellular events linking early metabolic stress to subsequent neuronal injury and neurodegenerative processes remain poorly defined.
    RESULTS: Here, we demonstrate that high-fat diet (HFD) triggers microglia to release pathogenic migrasomes (long-lived organelle-like vesicles) that promote neuronal injury, during an early phase of metabolic stress, before the emergence of overt dyslipidemia, hyperglycemia, and vascular pathology. We found that HFD feeding remodels the lipid environment of myelin-rich white matter and disrupts myelin homeostasis. Upon phagocytosis of this altered myelin, microglia generate migrasomes enriched with the neurotoxic alarmin S100A9. The pathogenicity of these vesicles was supported by complementary gain- and loss-of-function studies: intracerebral injection of HFD-induced microglial migrasomes was sufficient to impair cognition and induce neuronal injury in healthy mice, whereas Tspan9 conditional knockout in Cx3cr1-CreERT2 mice markedly reduced migrasome formation and thereby attenuated HFD-induced neurotoxicity. Mechanistically, we show that S100A9 is sorted into migrasomes post-myelin phagocytosis and is a critical mediator for their neurotoxic effects.
    CONCLUSIONS: These results uncover a metabolic-myelin-migrasome axis as a critical driver of neuronal injury and cognitive decline, identifying the blockade of microglial migrasome biogenesis as a potential therapeutic strategy for metabolism-associated neurological dysfunction.
    Keywords:  High-fat diet; Microglia; Migrasome; Neurotoxicity
    DOI:  https://doi.org/10.1016/j.metabol.2026.156841
  2. J Neuroinflammation. 2026 Aug 18. pii: 367. [Epub ahead of print]23(1):
      Primary central nervous system lymphoma (PCNSL) is a CNS-restricted lymphoma with poor prognosis. Despite sharing pathological features with systemic diffuse large B-cell lymphoma (DLBCL), PCNSL exhibits unique molecular mutation patterns, highlighting the critical role of the intracranial tumor microenvironment (TME). However, the role of microglia within TME remains poorly understood. Here, integrative analysis of single-cell transcriptomic data from systemic DLBCL and PCNSL reveals a distinct TME in PCNSL characterized by a heightened immunosuppressive state via microglia. Here, we identify a subpopulation of ARG1⁺ microglia enriched in the PCNSL tumor core, representing activated morphology and reduced branching complexity. Functionally, these microglia exhibit enhanced cytokine secretion via upgrading PI3K-AKT signal pathway, thereby remodeling the TME and ultimately promoting tumor progression. Targeting this microglia subtype with resveratrol, a bioactive small molecule, resulted in significant tumor suppression in vivo and vitro, accompanied by reduced expression of immunosuppressive cytokines and functional reprogramming of microglia. Collectively, our findings identify ARG1⁺ microglia as key orchestrators of the immunosuppressive TME in PCNSL through secretion cytokine and highlight microglia-targeted modulation by resveratrol as a potential therapeutic strategy.
    Keywords:  ARG1; Microglia; PCNSL; Tumor microenvironment
    DOI:  https://doi.org/10.1186/s12974-026-04004-w
  3. J Transl Med. 2026 Aug 17. pii: 1417. [Epub ahead of print]24(1):
       BACKGROUND: Diabetic retinopathy (DR) is a sight-threatening microvascular complication characterized by blood-retina barrier (BRB) disruption. While inflammation is central to early DR, the role of the non-canonical NF-κB pathway remains poorly understood.
    METHODS: We established a murine DR model and performed RNA-seq. Retinal microglial activation and the expression of NF-κB-inducing kinase (NIK) were assessed via immunohistochemistry and Western blot. In vitro, we employed AGEs-treated HMC3 microglia and a co-culture system with human retinal microvascular endothelial cells (hRMECs) under NIK knockdown or pharmacological inhibition (using the NIK inhibitor B022). Molecular mechanisms were delineated using ChIP-qPCR and pathway analysis.
    RESULTS: RNA-seq revealed significant enrichment of non-canonical NF-κB signaling in DR. NIK was significantly upregulated in DR retinas, specifically in microglia. NIK knockdown in vitro attenuated microglial activation, suppressed pro-inflammatory M1 markers (iNOS, TNF-α, IL-1β, IL-6), and promoted anti-inflammatory M2 markers (Arg-1, IL-10). Mechanistically, NIK drives microglial polarization via the non-canonical NF-κB pathway (IKKα/p52). In co-culture, NIK knockdown or B022 treatment rescued hRMECs from AGEs-activated microglia-induced dysfunction, improving viability, reducing apoptosis, and restoring barrier integrity. Intravitreal administration of B022 in DR mice mitigated retinal vascular leakage, reduced apoptosis, and rebalanced M1/M2 polarization.
    CONCLUSIONS: Our study identifies NIK as a master regulator of microglial polarization in DR via non-canonical NF-κB signaling. By disrupting BRB integrity, NIK-driven neuroinflammation is a critical pathogenic mechanism. The NIK inhibitor B022 demonstrates strong therapeutic potential, positioning NIK as a novel molecular target for treating diabetic retinopathy.
    DOI:  https://doi.org/10.1186/s12967-026-08728-4
  4. Front Immunol. 2026 ;17 1979527
       Background: Traumatic brain injury (TBI) triggers a rapidly evolving neuroinflammatory response that contributes to secondary brain injury. Although infiltrating leukocytes and resident microglia are both prominent components of this response, the cellular signals that connect peripheral immune-cell recruitment to microglial state remodeling remain incompletely defined.
    Methods: We integrated and reanalyzed publicly available single-cell RNA-sequencing datasets from mouse TBI models to define temporal changes in brain-cell composition and transcriptional states. CellChat and NicheNet were used to prioritize candidate neutrophil-to-microglia signaling pathways. The predicted cellular distribution of C3 and C3aR1 was evaluated by immunofluorescence and flow cytometry. The effects of JR14a treatment on microglial inflammatory responses, blood-brain barrier (BBB) integrity, and neurological outcomes were examined in a mouse TBI model. Single-Cell rEgulatory Network Inference and Clustering (SCENIC), CellOracle, a gene regulatory network inference and in silico transcription-factor perturbation framework, and scTenifoldKnk, a single-cell gene regulatory network-based virtual knockout framework, were used for gene regulatory network inference and in silico transcription-factor perturbation analyses in C3ar1-high microglia.
    Results: Analysis of 254,512 cells revealed a transient increase in infiltrating neutrophils during the acute phase of TBI and the emergence of inflammatory microglial states. CellChat and NicheNet independently prioritized C3-associated signaling between neutrophils and Microglia4. C3 expression was enriched in infiltrating neutrophils, whereas C3ar1 was preferentially expressed by inflammatory microglia. Flow cytometry showed that C3aR1-positive microglia expressed higher levels of IL-1β and TNF-α than C3aR1-negative microglia. JR14a treatment reduced microglial inflammatory cytokine production, preserved Claudin-5 expression, limited Evans blue extravasation, and improved neurological and cognitive outcomes after TBI. Exploratory regulatory analyses further prioritized Ets2, Fosl2, and Irf7 as candidate regulators of the C3ar1-high microglial program.
    Conclusions: These findings implicate a neutrophil-associated C3/C3a-C3aR1 communication pathway in inflammatory microglial remodeling after TBI and support further investigation of C3aR1-associated signaling as a therapeutic target for secondary neuroinflammation.
    Keywords:  C3aR1; complement C3; microglia; neuroinflammation; neutrophils; traumatic brain injury
    DOI:  https://doi.org/10.3389/fimmu.2026.1979527
  5. CNS Neurosci Ther. 2026 Nov;pii: e71268. [Epub ahead of print]32(11):
       BACKGROUND: Sepsis-associated encephalopathy (SAE) is a frequent neurological complication of sepsis characterized by acute neurobehavioral abnormalities and persistent cognitive impairment. Although 4-octyl itaconate (4-OI) possesses potent immunomodulatory properties, its neuroprotective effects and underlying mechanisms in SAE remain unclear.
    METHODS: Sepsis was induced by cecal ligation and puncture (CLP), and mice were treated with 4-OI. Behavioral tests were used to assess anxiety-like behavior and cognitive function. Transcriptomic and single-cell RNA-seq analyses were performed to characterize efferocytosis-related changes in the septic hippocampus. Western blot, immunofluorescence, flow cytometry, experiments using primary neutrophils and microglia, pharmacological interventions, and Padi4-/- mice were used to investigate NET formation and microglial efferocytosis.
    RESULTS: 4-OI improved neurobehavioral and cognitive outcomes, reduced hippocampal injury, blood-brain barrier disruption, and neuroinflammation, and suppressed NET accumulation in the septic hippocampus and LPS-stimulated neutrophils. NRF2 inhibition weakened the effects of 4-OI on neutrophil PD-L1 expression and NET formation, whereas PD-L1 neutralization reduced NET formation. Transcriptomic analyses identified microglia/myeloid-associated efferocytosis programs. NETs impaired microglial efferocytosis, while DNase I treatment or PAD4 deficiency preserved apoptotic cell clearance.
    CONCLUSIONS: 4-OI protects against septic brain injury and cognitive dysfunction by activating NRF2, suppressing PD-L1-mediated NET formation, and mitigating NET-associated impairment of microglial efferocytosis.
    Keywords:  4‐octyl itaconate; microglial efferocytosis; neutrophil extracellular traps; sepsis‐associated encephalopathy
    DOI:  https://doi.org/10.1002/cns.71268
  6. Acta Neuropathol Commun. 2026 Aug 17. pii: 236. [Epub ahead of print]14(1):
      Depression entails a range of pathological processes in the brain, typically characterized by altered microglial state, neural dysfunction, and vascular dysregulation. While it is well established that activated microglia inflict damage to neurons through direct and indirect microglia-neuron interactions, their interaction with vasculature and the associated regulation of vascular structure and function in depression remain poorly understood. Here, using a mouse model of depression induced by chronic unpredictable stress (CUS), we find that in stressed mice, activated microglia present reduced motility and decreased contact area with vasculature, which is accompanied by pathological vascular structure and function, characterized by reduced vessel density, narrowed vascular diameters, and sluggish blood flow velocity. We observe that vascular structure in the stressed mice is rapidly modified by the vessel-associated microglia (VAM). These VAM show upregulated angiotensin II type 1 receptor (AT1R) expression, which is not present in the vascular-uncontacted microglia. Furthermore, we demonstrate that AT1R signaling together with altered microglial state under chronic stress are critical mediators for the altered microglia-vascular interactions, vascular dysregulation, as well as the depression-like behaviors. Together, our findings reveal that under CUS, the aberrant microglial-vascular interaction, including the dysregulated microglial vasoregulation arising from AT1R signaling and altered microglial state, leads to depression, forging a new link between chronic stress and depression.
    Keywords:  AT1R signaling; Altered microglial state; Chronic stress; Depression-like behaviors; Microglial-vascular interaction; Vasoregulation
    DOI:  https://doi.org/10.1186/s40478-026-02406-8
  7. Glia. 2027 Jan;pii: e70249. [Epub ahead of print]75(1):
      Microglial responses to cerebral ischemia are tightly regulated by inhibitory pathways that limit excessive post-stroke inflammation. Transmembrane protein 119 (Tmem119) has emerged as an important regulator of microglial activation and neuroinflammatory signaling. We investigated the role of microglial Tmem119 during acute ischemic stroke using primary microglia and a young adult mouse model. Primary microglia were transfected with Tmem119-siRNA and subjected to oxygen-glucose deprivation (OGD) alone or combined with lipopolysaccharide (LPS) stimulation. In vivo, young adult male mice received stereotaxic injection of lenti-Tmem119 or lenti-GFP for 4 weeks before 60 min of transient middle cerebral artery occlusion (MCAO). Tmem119 expression and inflammatory responses were assessed by qPCR, Western blotting, and ELISA at 1 and 3 days after stroke. Infarct volume and neurobehavioral outcomes were also evaluated. Tmem119 silencing significantly increased IRAK4, IRF5, and CD68 mRNA expression in primary microglia. Ischemic injury reduced microglial Tmem119 protein expression and increased IRAK4 signaling in vivo. In contrast, lenti-Tmem119 treatment before MCAO decreased phosphorylated IRAK4 protein expression and increased IL-10 levels in both plasma and ischemic brain tissue compared with lenti-GFP controls. Tmem119 overexpression also significantly reduced infarct volume and improved neurobehavioral outcomes. These findings demonstrate that microglial Tmem119 exerts a protective anti-inflammatory role during the acute phase of ischemic stroke by suppressing IRAK4-mediated inflammatory signaling and enhancing IL-10 production. Collectively, Tmem119 limits microglial activation, reduces ischemic brain injury, and improves functional recovery, identifying Tmem119 as a promising therapeutic target for ischemic stroke.
    Keywords:  IRAK4; Tmem119; inflammation; ischemic stroke; microglia
    DOI:  https://doi.org/10.1002/glia.70249
  8. Mol Neurobiol. 2026 Nov 13. pii: 1033. [Epub ahead of print]63(1):
      Diabetes-associated cognitive dysfunction (DACD) is a significant complication with few effective treatments and unclear underlying mechanism. The aim of this study was to investigate how hyperglycemia disrupts adult hippocampal neurogenesis (AHN) through metabolic-immune interactions, seeking to identify potential treatment targets for DACD. DACD models were developed using db/db mice or streptozotocin-induced mice, and their cognitive function was assessed through behavioral tests. Next, we integrated multi-omics analyses (transcriptomic, single-cell, and lactylome profiling) with metabolic studies in BV2 cells exposed to diabetic conditions. Pharmacological modulators (3-BP, C646, TSA) were used to clarify the underlying mechanisms. The mice with DACD demonstrated cognitive deficits, impaired AHN, and activation of hippocampal microglia. Transcriptomic analysis revealed glycolysis as the primary dysregulated pathway. Mechanistically, hyperglycemia/AGEs induced glycolytic reprogramming and increased lactate levels, which promoted HIF-1α lactylation at lysine residues-a modification catalyzed by p300 and opposed by histone deacetylases. This posttranslational modification was associated with HIF-1α stabilisation and with enhanced transcriptional occupancy at the HK2 promoter. This established a self-amplifying feedback loop, perpetuating microglial activation and disrupting the blood-brain barrier via CXCL10 secretion, which led to CD8+ T-cell infiltration. Systemic administration of the glycolytic inhibitor 3-BP disrupted the pathogenic circuit, thereby normalizing metabolism, attenuating neuroinflammation, and restoring cognitive function. HIF-1α lactylation is associated with HIF-1α stabilisation, acting as a potential metabolic-epigenetic mechanism that links glycolytic flux to sustained microglial activation, neuroinflammation and impaired AHN in DACD. Pharmacological inhibition of this axis attenuated neuroinflammation and improved cognitive outcomes in our model, suggesting a candidate therapeutic strategy for DACD.
    Keywords:  Diabetic-associated cognitive dysfunction; Glycolysis; Hexokinase; Hypoxia-inducible factor 1-alpha; Lactylation
    DOI:  https://doi.org/10.1007/s12035-026-06348-z
  9. Mol Neurobiol. 2026 Nov 09. pii: 1024. [Epub ahead of print]63(1):
      Cofilin-1, an actin-binding protein, modulates cytoskeletal dynamics and cellular motility. Although its role in conditional neuron knockout (KO) and neuronal injury has been well studied, the specific deletion of cofilin-1 in microglia and its role in neuroinflammation after intracerebral hemorrhage (ICH) remains unknown. This study aimed to characterize the effects of microglia-specific cofilin-1 deficiency on microglial morphology, homeostasis, behavioral phenotypes, and neurobehavioral and neuroinflammatory outcomes following ICH in male and female mice. A conditional KO mouse model was generated by crossing cofilinfl/fl (Flx) mice with CX3CR1-Cre drivers to achieve microglia-specific deletion. Baseline behavioral performance, microglial morphology, and homeostatic markers were evaluated in both sexes. ICH was then induced by intra-striatal collagenase injection, and neurobehavioral function, brain edema, hematoma volume, microglial activation, and peripheral immune responses were evaluated three days post-injury. Microglial deletion of cofilin-1 was associated with reduced TMEM119 expression, increased IBA1 immunoreactivity, and morphological transformation toward an activated phenotype. Female KO mice showed pronounced hyperlocomotion and decreased anxiety-like behavior, whereas both sexes exhibited impaired neuromuscular performance in the wire hang test. After ICH, KO mice had significantly larger hematoma volumes, enhanced microglial activation, and increased peripheral leukocyte counts compared with Flx controls. Notably, these changes were more severe in female KO mice, indicating a sex-dependent vulnerability. Our findings establish cofilin-1 as a key regulator of microglial homeostasis and immune balance within the brain. Deficiency of microglial cofilin-1 predisposes to worse secondary brain injury after ICH in a sex-dependent manner.
    Keywords:  Behavioral phenotypes; Cofilin-1; Intracerebral hemorrhage; Microglia; Neuroinflammation; Sex differences
    DOI:  https://doi.org/10.1007/s12035-026-06324-7
  10. mBio. 2026 Nov 12. e0236526
      Microglia are major targets of HIV-1 in the brain. Despite effective antiviral therapy, infected microglia, including those containing a replication-defective provirus, can express viral products that contribute to neuroinflammation, yet how productive infection shapes the host response remains poorly defined. Using single-cell RNA-seq of HIV-1-infected C20 microglia, we stratified cells by HIV-1 splice junction-supporting reads into low- and high-infection groups, resolving a graded rather than binary host transcriptional response. The computational pipeline developed for this quantification is made publicly available. A core set of immune and cell cycle pathways was induced, regardless of infection level, but several programs reversed direction with increasing viral burden: interferon-α/γ and EMT/hypoxia signatures peaked at low infection, while high infection featured suppression of these signatures alongside induction of mTORC1/MYC signaling, ribosome biogenesis, RNA processing, and mitotic activity, with progressive loss of cytoskeletal, motility, and developmental programs. This pattern, except for cell cycle/mitotic signatures, was reproduced in iPSC-derived microglia, supporting its generalizability beyond an immortalized cell line. To identify potential regulatory mechanisms underlying these transcriptional programs, we integrated differentially expressed miRNAs and genes from the low- and high-infection groups, filtered for the canonical inverse miRNA-target relationship, revealing miRNA/mRNA networks enriched for miRNAs previously implicated in HIV-1 replication (e.g., miR-33a-5p and miR-3065-3p) and in neurodegenerative and psychiatric disease (e.g., miR-107 and let-7c-5p). These findings define a productive infection-level continuum in microglial transcription and miRNA reprogramming and identify candidate miRNA-mediated mechanisms, complementary to the canonical Env/Nef/Tat pathway by which HIV-1-infected microglia may contribute to neuroinflammation and neurocognitive impairment in people with HIV-1.IMPORTANCEHIV-1 persists in the brain despite antiviral therapy in part because infected microglia continue to express viral RNA and proteins that promote neuroinflammation, contributing to the cognitive impairment seen in many people with HIV-1. How the level of active viral replication within a microglial cell shapes its response has been unclear since most infection models capture only an averaged, post-replication snapshot rather than the transition from low to advanced infection. By ranking microglia by HIV-1 splice junction-supporting reads, we show that the host transcriptional response is graded rather than binary, and that several pathways, including interferon and growth/proliferative signaling, reverse direction as viral load increases. We further identify a network of HIV-1-dysregulated miRNAs, several previously linked to viral replication or to neurodegenerative and neurocognitive disease, pointing to a mechanism by which infected microglia may influence neuronal health, complementary to the well-studied viral Env, Nef, and Tat proteins.
    Keywords:  HIV-1; miRNAs; microglia; scRNAseq
    DOI:  https://doi.org/10.1128/mbio.02365-26
  11. Brain Pathol. 2026 Nov 11. pii: e70157. [Epub ahead of print]
      Colony-stimulating factor 1 receptor (CSF1R)-associated leukoencephalopathy (CSF1R-LE) is a fatal genetic white matter disease, whose onset is most commonly in mid-age adulthood, and is characterized by rapid neurological decline and premature death within a few years after disease onset. CSF1R is exclusively expressed by microglia in the parenchyma of the adult central nervous system, thus defining CSF1R-LE as a paradigmatic primary microgliopathy. However, the cellular alterations that drive the sudden onset and rapid progression of the disease remain largely unknown. Therefore, the investigation of microglia phenotypes in human histopathological tissue, particularly considering the spatial evolution of the pathology, can provide crucial insights into the disease-causing mechanisms. In this study, we (immuno-) histochemically characterized myeloid cell pathology in relation to the extent of damage to the axon-myelin unit in five autopsy cases of CSF1R-LE. A particular focus was on the relationship between microglia phenotypes and the pronounced iron accumulation observed in this disease. Our findings provide evidence that the early loss of homeostatic microglia and inflammatory activation of remaining myeloid cells are key components of areas with mild tissue pathology. Furthermore, we demonstrate a marked and progressive accumulation of iron within myeloid cells paralleling increasing white matter damage. This process is associated with ongoing myelin degeneration and occurs in the apparent absence of efficient remyelination. In summary, our study reveals stage-specific myeloid cell pathology in CSF1R-LE and highlights a specific spatial heterogeneity that should be considered when studying this disease. Moreover, our findings suggest that cellular iron accumulation may not only contribute to disease progression but may also represent a promising and clinically accessible biomarker for CSF1R-LE.
    Keywords:  CSF1R; leukodystrophy; microglia
    DOI:  https://doi.org/10.1111/bpa.70157
  12. Neuropharmacology. 2026 Nov 10. pii: S0028-3908(26)00433-8. [Epub ahead of print]303 111258
      Previously, the results of our clinical study have suggested that circadian rhythm have an impact on neurological outcomes following cardiac arrest and cardiopulmonary resuscitation (CA/CPR), but the underlying mechanisms remain unknown. Here, using a mouse model of CA/CPR, we aimed to unravel the underlying mechanisms of the diurnal variation in CA/CPR-induced brain injury. The mice received 5 min of CA either in the active phase or in the inactive phase. To identify novel therapeutic targets for the impact of circadian rhythm on CA/CPR-induced brain injury, we applied high throughput RNA-seq analysis to profile mRNAs with differentially expression in the hippocampus of the two groups. Since it has been reported that CMKLR1 is beneficial for inhibiting neuroinflammation and improving neurological outcomes among many neurological diseases, we centered on this gene and clarified that its main cellular source is microglia. The correlation between CMKLR1 expression in hippocampus and neurological outcomes after CA/CPR was elucidated by CMKLR1 activation and knockout in microglia. The impact of CMKLR1 on microglial function, especially glucose metabolism, was clarified using BV2 microglia cell line by glucose uptake analysis, seahorse analysis and carbon 13 tracing. As a result, CA/CPR happening at active phase leads to better neurological outcomes with upregulation of microglial CMKLR1 in the hippocampus of mice. Our findings suggest that elevated microglial CMKLR1 expression in the hippocampus contributes to improved neurological outcomes after CA/CPR by promoting lactate production in microglia.
    Keywords:  Brain injury; Cardiac arrest; Cardiopulmonary resuscitation; Circadian rhythm; Lactate; Microglia
    DOI:  https://doi.org/10.1016/j.neuropharm.2026.111258
  13. Brain Behav Immun Health. 2026 Dec;58 101395
      Anxiety disorder is a serious psychiatric disease that affects women more than men and disrupts patients' daily lives. It is often comorbid with major depression and other mental diseases. Various underlying mechanisms have been proposed, such as neurotransmitters and neuroanatomical disruptions, and more recently, oxidative stress; however, much remains unclear, including the role of glial cells. Here, we investigated the role of IRF8 in anxiety-like behavior using mouse models. IRF8 is a transcription factor expressed primarily in microglia in the brain. A battery of behavioral tests revealed that female IRF8 knockout (IRF8KO) mice show increased anxiety-like behavior relative to male IRF8KO and wild-type mice. Female IRF8KO mice also exhibited a higher tendency for obsessive-compulsive-like disorder. However, these behavioral abnormalities were not observed when IRF8 was deleted postnatally, indicating that it acts during the fetal stage to control anxiety-like behavior. Transcriptome analysis revealed that IRF8 deficiency leads to redox dysregulation. Further, 2',7'-dichlorofluorescin diacetate (DCFDA) staining for microglia demonstrated that female IRF8KO microglia produce higher levels of reactive oxygen species (ROS) compared to WT and male IRF8KO counterparts. Detailed RNA-seq analysis, however, did not reveal specific genes that cause high ROS production in female cells. In sum, this work demonstrates that IRF8 in microglia plays a major role in controlling anxiety and OCD-like behavior with potential sex-specific differences.
    Keywords:  Anxiety-like behavior; IRF8; Microglia; Obsessive-compulsive disorder; Reactive oxygen species
    DOI:  https://doi.org/10.1016/j.bbih.2026.101395
  14. Neuroscience. 2026 Nov 10. pii: S0306-4522(26)00739-6. [Epub ahead of print]
      Previous studies have shown that amyloid-β (Aβ) oligomers are implicated in the pathogenesis of Alzheimer's disease (AD). Aβ oligomers include various molecules with distinct characteristics, such as dimers and trimers; among these, Aβ dimers have been found to possess neurotoxicity. This study found that Aβ dimers can induce microglial proliferation, enhanced phagocytosis, and pro-inflammatory polarization in the mouse brain even before cognitive impairment occurs, and this effect was validated in vitro using BV2 cells. Mechanistically, Aβ dimers bind to the microglial receptor TLR2, activating the downstream NF-κB signaling pathway and upregulating the expression of inflammatory factors. Knocking down TLR2 significantly reverses the Aβ dimer-induced inflammatory response and alleviates microglial-mediated neuronal damage. Furthermore, repeated intracerebral injections of Aβ dimers lead to impaired learning and memory in mice, as well as loss of hippocampal neurons and synapses; these changes are independent of amyloid plaque deposition and tau protein hyperphosphorylation. In summary, Aβ dimers induce early neuroinflammation and cognitive deficits by binding to TLR2 on microglia, providing a new molecular target for early intervention in AD.
    Keywords:  Alzheimer’s disease; Aβ dimer; Microglia; Neuroinflammation; TLR2
    DOI:  https://doi.org/10.1016/j.neuroscience.2026.11.017